Mersana Therapeutics, Inc.
B7H4-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

Abstract:

The present disclosure relates generally to antibody-drug conjugates comprising monoclonal antibodies that specifically bind the human B7-H4 in soluble form, or membrane bound (i.e., when expressed on a cell surface) and to methods of using these conjugates as therapeutics and/or diagnostics.